To launch a drug in the ultra-rare disease space, the path to commercialization is narrow. In developing the first treatment ...
GSK (GSK) reported a study showed its drug belantamab mafodotin was able to reduce the risk of death by 42% in certain ...
The National Medical Commission (NMC) has released its first-ever set of guidelines to identify "fake patients" in medical ...
Stock futures edged lower Monday morning as investors eye this week’s key inflation report. The Consumer Price Index (CPI) ...
From powerful, data-driven insights and strategic consultancy support to agenda-setting events and hiring solutions, our products and services enable everyone in higher education to make smarter, more ...
The U.S. dermal fillers market has become one of the most rapidly growing sectors within the broader cosmetic and ...
(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...
Women's health hubs will be set up in every part of the country by 2026 in an effort to help close the gender health gap. It ...
CurePSP, Inc. ("CurePSP") and GemVax & KAEL Co., Ltd. ("GemVax"; KOSDAQ: 082270) have announced the establishment of Korea's ...
Lesley spent more than four years at Merck & Co. (NYSE: MRK) and about 19 years at the Genomics Institute of the Novartis ...
Nvidia experts across accelerated computing, data science and research predict multimodal models will speed industry innovation and efficiency. From boardroom to break room, generative AI took this ...
US markets have pulled back from recent highs, with tech stocks leading the decline. The S&P 500 fell 0.61% to 6,052.85, while the Nasdaq dropped 0.62% to 19,736.69. The Dow Jones lost 241 points, ...